Annals of vascular surgery · 2026
Stenting of the Inferior Mesenteric Artery as a Single Vessel Treatment for Chronic Mesenteric Ischemia.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
El-Qawaqzeh Khaled, Babu Sateesh, Goyal Arun, Stafford Nicholas, Rahaman Zakiur, Madris Brandon, Laskowski Igor, Mateo Romeo
Аннотация
PURPOSE: Angioplasty and stenting of the mesenteric arteries have increasingly become the first therapeutic option for CMI. The superior mesenteric artery (SMA) and the celiac artery (CA) have been the usual targets for revascularization. However, published data on stenting of only the inferior mesenteric artery (IMA) for this disease are limited. This study evaluated the results in 10 patients treated at our institution.
STUDY DESIGN: A retrospective review of 10 patients who underwent angioplasty and stenting of only the IMA for symptomatic CMI from 2005 to 2025. Patient demographics, angiographic findings, procedural details, and outcomes were recorded.
RESULTS: Four males and six females with a mean age of 68 years (range 50-85) underwent angioplasty and stenting of the IMA as a single vessel. Nine patients were treated with balloon expandable bare metal stents. One was treated with a drug eluting stent. All patients had critical IMA stenosis. Five patients had occlusions or critical stenosis of both the SMA and CA. Five patients had nonobstructive disease of the SMA and CA. Technical success was 100% and immediate clinical improvement of CMI symptoms occurred in all patients. The follow-up period ranged from 0 to 10 years after the procedure. At their last follow-up or at the time of death, all patients remained free of recurrent mesenteric ischemic symptoms.
CONCLUSIONS: Under certain clinical and angiographic situations, angioplasty and stenting of the IMA as a single vessel treatment can be safely performed in patients with CMI with satisfactory short- and long-term outcomes.
STUDY DESIGN: A retrospective review of 10 patients who underwent angioplasty and stenting of only the IMA for symptomatic CMI from 2005 to 2025. Patient demographics, angiographic findings, procedural details, and outcomes were recorded.
RESULTS: Four males and six females with a mean age of 68 years (range 50-85) underwent angioplasty and stenting of the IMA as a single vessel. Nine patients were treated with balloon expandable bare metal stents. One was treated with a drug eluting stent. All patients had critical IMA stenosis. Five patients had occlusions or critical stenosis of both the SMA and CA. Five patients had nonobstructive disease of the SMA and CA. Technical success was 100% and immediate clinical improvement of CMI symptoms occurred in all patients. The follow-up period ranged from 0 to 10 years after the procedure. At their last follow-up or at the time of death, all patients remained free of recurrent mesenteric ischemic symptoms.
CONCLUSIONS: Under certain clinical and angiographic situations, angioplasty and stenting of the IMA as a single vessel treatment can be safely performed in patients with CMI with satisfactory short- and long-term outcomes.